LONDON: A diabetes drug has been authorised to help obese and overweight adults with weight management and loss, according to the Medicines and Healthcare products Regulatory Agency (MHRA).Such patients with weight-related health problems - such as prediabetes, high blood pressure, high cholesterol or heart problems - could have access to Tirzepatide if it receives further approval from the National Institute for Health and Care Excellence (NICE), said PA Media.The weight loss jab, also known as Mounjaro, was given the green light for NHS use in September by Nice as an option for patients with type 2 diabetes who do not have the condition under control.Of its use for weight management, Healt
Hence then, the article about uk regulator diabetes drug authorised for weight management and loss was published today ( ) and is available onDaily Sun ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( UK Regulator: Diabetes drug authorised for weight management and loss )